Tuberculosis in Europe: A problem of drug resistance or much more?

Expert Review of Respiratory Medicine

Volumn 4, Issue 2, 2010, Pages 189-200

  Carvalho, Anna C C ^a   Migliori, Giovanni B ^b   Cirillo, Daniela M ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Maugeri Care and Research Institute   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Elderly; Epidemiology; Europe; HIV infection; MDR TB; Substance abuse; TB; Tuberculosis; XDR TB

Indexed keywords

ISONIAZID; RIFAMPICIN;

AGING; ALCOHOLISM; ANTIBIOTIC RESISTANCE; DRUG DEPENDENCE; EUROPE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; INCIDENCE; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; PRISONER; REVIEW; RISK FACTOR; SHORT COURSE THERAPY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 77951443140     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.10.7     Document Type: Review

References (87)

1. Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in Western Europe. Bull. World Health Organ. 71, 297-306 (1993).
2. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328, 521-526 (1993).
3. Willcox PA. Drug-resistant tuberculosis: worldwide trends, problems specific to Eastern Europe and other hotspots, and the threat to developing countries. Curr. Opin. Pulm. Med. 7, 148-153 (2001).
4. Dye C. Global epidemiology of tuberculosis. Lancet 367, 938-940 (2006).
5. Wright A, Zignol M, Van Deun A et al. Epidemiology of antituberculosis drug resistance 2002-2007: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373, 1861-1873 (2009).
6. Drobniewski FA, Balanova YM, Ruddy MC et al. Tuberculosis, HIV seroprevalence and intravenous drug use in prisioners. Eur. Respir. J. 26, 298-304 (2005).
7. Falzon D, Aït-Belghit F. What is tuberculosis surveillance in the European Union telling us? CID 44, 1261-1267 (2007).
8. Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Kourbatova EV. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int. J. Tuberc. Lung Dis. 11, 353-354 (2007).
9. Dubos R, Dubos J. The White Plague: Tuberculosis, Man, and Society. Rutgers University Press, NJ, USA (1987).
10. Chretien J. Tuberculosis. The Illustrated History of a Disease. Volume 1. The Union, Paris, France (1998).
11. Rieder HL, Cauthen GM, Comstock GW, Snider DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol. Rev. 11, 79-98 (1989).
12. Davies R, Tocque K, Bellis M, Rimmington T, Davies P. Historical declines in tuberculosis in England and Wales: improving social conditions or natural selection? Int. J. Tuberc. Lung Dis. 3, 1051-1054 (1999).
13. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc. Sci. Med. 68, 2240-2246 (2009).
14. Centers for Disease Control (CDC). Tuberculosis, final data: United States 1986. Morb. Mortal. Wkly Rep. 36, 817-820 (1988).
15. Raviglione M, Uplekar M. WHO's new Stop TB strategy. Lancet 367, 952-955 (2006).
16. Velasco M, Castilla V, Cervero M et al.; for the COMESEM cohort. The changing pattern of tuberculosis and HIV co-infection in immigrants and Spaniards in the last 20 years. HIV Med. 9, 227-233 (2008).
17. Leimane V, Leimans J. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes. Eur. Surveill. 11, 29-33 (2006).
18. Broekmans JF, Migliori GB, Rieder HL et al. European framework for tuberculosis control and elimination in countries with a low incidence. Eur. Respir. J. 19, 765-775 (2002).
19. Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V. Epidemiology and control of tuberculosis in Western European cities. Int. J. Tuberc. Lung Dis. 8, 751-757 (2003).
20. Zipperer M. Tackling tuberculosis in Latvia. PLoS Med. 2(5), e122 (2005).
21. Vynnycky E, Borgdoff MW, Leung CC, Tam CM, Fine PE. Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiol. Infect. 136, 943-952 (2008).
22. Tocque K, Bellis MA, Tam CM et al. Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales. Am. J. Respir. Crit. Care Med. 158, 484-488 (1998).
23. Davies PDO, Woo J, Moore-Gillon J. Tuberculosis in the elderly. In: Tuberculosis. A Comprehensive International Approach (3rd Edition). Raviglione MC (Ed.). Informa Health Care, London, UK (2006).
24. Davies PDO. TB in the elderly in industrialised countries. Int. J. Tuberc. Lung Dis. 11, 1157-1159 (2007).
25. Pešut DP, Gledović ZB, Grgurević AD, Nagorni-Obradović LM, Adžić TN. Tuberculosis incidence in elderly in Serbia: key trends in socioeconomic transition. Croat. Med. J. 49, 807-812 (2008).
26. Pérez-Gusmán C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis? Chest 116, 961-967 (1999).
27. Haanaes OC, Bergmann A. Tuberculosis emerging in patients treated with corticosteroids. Eur. J. Resp. Dis. 64, 229-237 (1983).
28. Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N. Engl. J. Med. 312, 1483-1487 (1985).
29. Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 114, 1244-1252 (1998).
30. Sime PJ, Chilvers ER, Leitch AG. Miliary tuberculosis in Edinburgh - a comparison between 1984-1992 and 1954-1967. Respir. Med. 88, 609-611 (1994).
31. Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect. Dis. 5, 415-430 (2005).
32. Rieder HL, Kelly GD, Bloch AB, Cauthen GM, Snider DEJ. Tuberculosis diagnosed at death in the United States. Chest 100, 678-811 (1991).
33. MacGee W. The frequency of unsuspected tuberculosis found post-mortem in a geriatric population. Z. Gerontol. 22, 311-314 (1989).
34. Humphries MJ, Byfield SP, Darbyshire JH et al. Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br. J. Dis. Chest 78, 149-158 (1984).
35. Martineau A, Lowey H, Tocque K, Davies POD. Case-fatality from tuberculosis by age and site in England and Wales. Int. J. Tuberc. Lung Dis. 8, 732-742 (2004).
36. Ijaz K, Dillaha JA, Yang Z, Cave MD, Bates JH. Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. J. Am. Geriatr. Soc. 50, 1213-1218 (2002).
37. Nisar M, Williams CS, Ashby D, Davies PD. Tuberculin testing in residential homes for the elderly. Thorax 48, 1257-1260 (1993).
38. Centers for Disease Control (CDC). Prevention and control of tuberculosis in facilities providing long-term care to the elderly recommendations of the advisory committee for elimination of tuberculosis. MMWR Recomm. Rep. 39, 7-20 (1990).
39. Gisselbrecht M. La tuberculose chez les personnes âgées en institution. Rev. Mal. Respir. 20, 912-913 (2003).
40. Centers for Disease Control and Prevention (CDC). Multidrug-resistant tuberculosis outbreak on an HIV ward - Madrid, Spain, 1991-1995. MMWR Morb. Mortal. Wkly Rep. 45, 330-333 (1996).
41. Moro ML, Gori A, Errante I et al. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. AIDS 18, 1095-1102 (1998).
42. Hannan MM, Peres H, Maltez F et al. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital, 1995-1996. J. Hosp. Infect. 47, 91-97 (2001).
43. Castilla J, Gutiérrez A, Guerra L et al. Pulmonary and extrapulmonary tuberculosis at AIDS diagnosis in Spain: epidemiological differences and implications for control. AIDS 11, 1583-1588 (1997).
44. Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Morb. Mortal. Wkly Rep. 58, 1-207 (2009).
45. Girardi E, Antonucci G, Vanacore P et al. Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. Eur. Respir. J. 24, 11-17 (2004).
46. Jones JL, Hanson DL, Dworkin MS, DeCock KM. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. Int. J. Tuberc. Lung Dis. 14, 1985-1991 (2000).
47. Girardi E, Antonucci G, Vanacore P et al. Impact of combination therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14, 1985-1991 (2000).
48. de Colombani P, Banatvala N, Zaleskis R, Maher D. European framework to decrease the burden of TB/HIV. Eur. Respir. J. 24, 493-501 (2004).
49. Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 62, 667-671 (2007).
50. van der Werf M J, Yegorova OB, Chentsova N et al. Tuberculosis-HIV co-infection in Kiev City, Ukraine. Emerg. Infect. Dis. 5, 766-768 (2006).
51. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch. Intern. Med. 139, 337-339 (1979).
52. Friedman LN, Sullivan GM, Bevilaqua RP, Loscos R. Tuberculosis screening in alcoholics and drug addicts. Am. Rev. Respir. Dis. 136, 1188-1192 (1987).
53. Braum MM, Truman BI, Maguire B et al. Increasing incidence of tuberculosis in a prison inmate population. JAMA 261, 393-397 (1989).
54. Zolopa AR, Hahn JA, Gorter R et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample. JAMA 272, 455-461 (1994).
55. Martin V, Caylà JA, Bolea A, Castilla J. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int. J. Tuberc. Lung Dis. 4, 41-46 (2000).
56. Story A, Bothamley G, Hayward A. Crack cocaine and infectious tuberculosis. Emerg. Infect. Dis. 9, 1466-1469 (2008).
57. Aerts A, Hauer B, Wanlin M, Veen J. Tuberculosis and tuberculosis control in European prisons. Int. J. Tuberc. Lung Dis. 11, 1215-1223 (2006).
58. Fleming MF, Krupitsky E, Tsoy M et al. Tuberculosis knowledge, perceived risk and risk behaviors among homeless adults: effect of ethnicity and injection drug use. J. Community Health 29, 483-497 (2004).
59. Szabo G. Alcohol's contribution to compromised immunity. Alcohol Health Res. World 21, 30-41 (1997).
60. Lonnroth K, Raviglione M. Global tuberculosis epidemiology - prospects for control. Semin. Respir. Crit. Care Med. 29, 481-491 (2008).
61. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health 8, 289 (2008).
62. Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S. Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. Int. J. Tuberc. Lung Dis. 10, 857-863 (2006).
63. Gelmanova IY, Keshavjee S, Golubchikova VT et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull. World Health Org. 85, 703-711 (2007).
64. van der Werf MJ, Chechulin Y, Yegorova OB et al. Health care seeking behaviour for tuberculosis symptoms in Kiev City, Ukraine. Int. J. Tuberc. Lung Dis. 10, 390-395 (2006).
65. Zaridze D, Brennan P, Boreham J et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48 557 adult deaths. Lancet 27, 2201-2214 (2009).
66. Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg. Infect. Dis. 8, 679-684 (2002).
67. Farah MG, Meyer HE, Selmer R, Heldal E, Bjune G. Long-term risk of tuberculosis among immigrants in Norway. Int. J. Epidemiol. 34, 1005-1011 (2005).
68. Kik SV, Olthof SPJ, de Vries JT et al. Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands. BMC Public Health 9, 283 (2009).
69. Farge D, Porcher R, Antoun F et al.; members of the TB-INFO Association. Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France. Int. J. Tuberc. Lung Dis. 11, 992-998 (2007).
70. Bothamley GH, Ditiu L, Migliori GB, Lange C; TBNET contributors. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur. Respir. J. 32, 1023-1030 (2008).
71. Coker R, Bell A, Pitman R et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur. Respir. J. 27, 801-807 (2006).
72. Hargreaves S, Carballo M, Friedland JS. Screening migrants for tuberculosis: where next? Lancet Infect. Dis. 9, 139-140 (2009).
73. Carvalho ACC, Saleri N, El-Hamad I et al. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol. Infect. 133, 179-185 (2005).
74. Bodenmann P, Vaucher P, Wolff H et al. Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive explanatory study. BMC Infect. Dis. 9, 34 (2009).
75. Lillebaek T, Andersen AB, Bauer J et al. Risk of Mycobacterium tuberculoisis transmission in a low-incidence country due to immigration from high-incidence areas. J. Clin. Microbiol. 39, 855-861 (2001).
76. Matteelli A, Gori A, Pinsi G et al. Clustering of tuberculosis among Senegalese immigrants in Italy. Int. J. Tuberc. Lung Dis. 7, 967-972 (2003).
77. Diel R, Rüsch-Gerdes S, Niemann S. Molecular epidemiology of tuberculosis among immigrants in Hamburg, Germany. J. Clin. Microbiol. 42, 2952-2960 (2004).
78. Del Amo J, Petruckevitch A, Philips AN et al. Risk factors for tuberculosis in patients with AIDS in London: a case-control study. Int. J. Tuberc. Lung Dis. 3, 12-17 (1999).
79. Espinal MA, Kim SJ, Suarez PG et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 283, 2537-2545 (2000).
80. Sotgiu G, Ferrara G, Matteelli A et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur. Respir. J. 33, 871-881 (2009).
81. Migliori GB, Ortmann J, Girardi E et al.; SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg. Infect. Dis. 5, 780-782 (2007).
82. Migliori GB, Besozzi G, Girardi E et al.; SMIRA/TBNET Study Group. Clinical and operational value of the XDR-TB definition. Eur. Respir. J. 30, 623-626 (2007).
83. Sotgiu G, Sorete-Arbore A, Kliimann K et al. Social determinants of MDR-TB in Europe: a multicentre TBNET study. Eur. Respir. J. 34(S53), 4446 (2009).
84. Wells CD, Peter Cegielski J, Nelson LJ et al. HIV infection and multidrug-resistant tuberculosis - the perfect storm. J. Infect. Dis. 196, S86-S107 (2007).
85. Drobniewski FA, Hoffner S, Rusch- Gerdes S, Skenders G. Recommended standards for modern tuberculosis laboratory services in Europe. Eur. Respir. J. 28, 903-909 (2006).
86. European Centre for Disease Prevention and Control (ECDC). Framework Action Plan to fight tuberculosis in the European Union. Stockholm, Sweden, February 2008.
87. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International Standards for Tuberculosis Care. Lancet Infect. Dis. 6, 710-725 (2006).